Creo Medical Group PLC (LON:CREO) Insider Kevin Crofton Purchases 1,179,000 Shares

Creo Medical Group PLC (LON:CREO) insider Kevin Crofton bought 1,179,000 shares of Creo Medical Group stock in a transaction on Friday, December 13th. The stock was acquired at an average price of GBX 17 ($0.22) per share, with a total value of £200,430 ($254,288.25).

Kevin Crofton also recently made the following trade(s):

• On Monday, October 21st, Kevin Crofton bought 2,916,666 shares of Creo Medical Group stock. The shares were bought at an average price of GBX 24 ($0.30) per share, for a total transaction of £699,999.84 ($888,099.26).

Creo Medical Group Stock Up 3.7 %

Shares of Creo Medical Group stock opened at GBX 17.50 ($0.22) on Tuesday. Creo Medical Group PLC has a 12-month low of GBX 12 ($0.15) and a 12-month high of GBX 50 ($0.63). The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96. The stock has a 50 day moving average price of GBX 18.21 and a two-hundred day moving average price of GBX 26.35. The stock has a market capitalization of £63.31 million, a P/E ratio of -291.67 and a beta of 0.86.

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.